03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock. sec.report To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible: In the Coronavirus Market: $COCP is to Treatment what $IBIO is to Vaccines or what $OPK is to Testing. $COCP has...
BOTHELL, WA,, March 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage Biotechnology company discovering and developing novel antiviral therapeutics, today announced it has initiated its Coronavirus program. finance.yahoo.com “Following our acquisition of patent rights and know-how from KSURF and...